BioAmp Diagnostics
San Carlos, US · 1 known investors
BioAmp Diagnostics develops a chemistry-based rapid diagnostic pipeline (DETECT: Dual-Enzyme Trigger-Enabled Cascade Technology) that delivers infection results in minutes to guide antibiotic prescribing, initially targeting complicated urinary tract infections. The technology is intended to help physicians select the correct antibiotic and support efforts to combat antibiotic resistance.
BiotechDigital HealthMedical Devices
Founders & leadership
TD
Tara DeBoerChief Executive Officer
AR
Angel ResendezDirector of Chemistry - Small Molecule Discovery, CSIO